Brenton Hamdorf, MBA
Chief Executive Officer, Celosia Therapeutics Pty Ltd
Dr. Hamdorf is a biotechnology entrepreneur with extensive experience in the commercialisation of biotechnologies, with a focus on business development, partnering, intellectual property and the management of early-stage opportunities. He holds a PhD in biochemistry and molecular biology from the University of New England and an MBA from Queensland University of Technology. He is also a Registered Technology Transfer Professional (RTTP) with more than 25 years’ experience in and around the technology transfer industry and company creation.